STXS Stereotaxis Inc.

AMEX
$0.88

Stereotaxis Inc. (STXS) is expected to report earnings on February 9, 2027, after the market close. The consensus earnings estimate is a loss of $0.05 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.2% since its last earnings release on November 10, 2026.

Stereotaxis Reported Earnings
Tuesday, November 10, 2026 · 4:02 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 9
Tuesday · 4:00 PM ET
Earnings Whisper
-
vs ($0.05)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.84

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Stereotaxis Inc.

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.